Search results - Portal of Medical Data Models (MDM-Portal)

Filter search results

Keywords

Pre-Study Form ×

Show more Keywords

Table of contents

Select data models

Selected data models

You must log in to select data models for download or further analysis.

73 Search results.

Pre-Study - PRIOR RADIATION SUPPLEMENT - 2398684v1.0 - PRIOR RADIATION SUPPLEMENT

- 9/20/21 - 1 form, 1 itemgroup, 11 items, 1 language

Itemgroup: PRIOR RADIATION SUPPLEMENT

Prior Radiation form for C3D 3.12 Adopters Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FF41EFA1-C05B-5480-E034-0003BA3F9857

Pre-Study - PRIOR SURGERY SUPPLEMENT - 2398212v1.0 - PRIOR SURGERY SUPPLEMENT

- 9/20/21 - 1 form, 2 itemgroups, 8 items, 1 language

Itemgroups: PRIOR SURGERY SUPPLEMENT,COMMENTS

Prior Surgery form for C3D 3.12 Adopters Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FF2F7B22-5065-707B-E034-0003BA3F9857

Prestudy form NSCLC Stage III NCT00020709

- 9/20/21 - 1 form, 4 itemgroups, 25 items, 1 language

Itemgroups: SWOG clinical trial administrative data,PATIENT AND DISEASE DESCRIPTION,CURRENT LABORATORY VALUES (SI UNITS),Notes

NCT00020709 S0023: Combination Chemo Plus RT With or Without Gefitinib in Treating Patients With Unresectable Stage III NSCLC Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9CA62D43-4AA8-361C-E034-080020C9C0E0

Lung Cancer NCT00863512 Pre-Study - CALGB 30506 Pre-Study/Surgical Resection Form - 2821782v1.0 - CALGB 30506 Pre-Study/Surgical Resection Form

- 9/20/21 - 1 form, 9 itemgroups, 46 items, 1 language

Itemgroups: Header Module,Header,Initial Laboratory Values,Smoking Status,Pre-surgical Disease Status,Surgical Disease Status,Planned Treatment,Contact Information,Footer Module

CALGB 30506 Pre-Study/Surgical Resection Form Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=5FE8C8A3-6705-BC07-E040-BB89AD4332A8

Lung Cancer NCT00946712 Pre-Study - Southwest Oncology Group S0819 Prestudy Form - 2863901v1.0 - Southwest Oncology Group S0819 Prestudy Form

- 9/20/21 - 1 form, 8 itemgroups, 72 items, 1 language

Itemgroups: Header Module,PATIENT AND DISEASE DESCRIPTION,PATIENT AND DISEASE DESCRIPTION1,LABORATORY VALUES,LABORATORY VALUES1,ADDITIONAL PRESTUDY DATA,PRIOR TREATMENT RELATED TO THIS CANCER,Comments

Southwest Oncology Group S0819 Prestudy Form Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=684FE956-5AAF-A7DA-E040-BB89AD432A2B

Pre-Study - BASELINE MEDICAL HISTORY - 2393057v1.0 - BASELINE MEDICAL HISTORY

- 9/20/21 - 1 form, 2 itemgroups, 5 items, 1 language

Itemgroups: BASELINE MEDICAL HISTORY,COMMENTS

Baseline Medical History form for C3D 3.12 Adopters Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FF0830C9-70C7-12CC-E034-0003BA3F9857

Pre-Study - NCI Standard Participant Identification Template - 2729615v1.0 - NCI Standard Participant Identification Template

- 9/20/21 - 1 form, 2 itemgroups, 11 items, 1 language

Itemgroups: Conditional Participant ID Questions,Optional Participant ID Questions

The collection of CDEs used in the Participant ID module. Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=46716FCE-3AD1-70D5-E044-0003BA3F9857

Cisplatin and Topotecan Recurrent or Persistent Carcinoma of the Cervix - 103369 - Pre-Treatment Summary Sheet

- 3/14/19 - 1 form, 5 itemgroups, 41 items, 1 language

Itemgroups: Administrative data,Physical Examination,Laboratory Findings,Measurable Mass,Performance Grade

Study ID: 103369 Clinical Study ID: 103369 Study Title: A Randomized Phase III Study of Cisplatin Versus Cisplatin plus Topotecan Versus MVAC in Stage IVB, Recurrent or Persistent Squamous Cell Carcinoma of the Cervix Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Topotecan Trade Name: Topotecan Study Indication: Cancer

Cisplatin and Topotecan Recurrent on Persistent Carcinoma of the Cervix - 103369 - Initial On Study Form

- 3/14/19 - 1 form, 5 itemgroups, 47 items, 1 language

Itemgroups: Administrative data,Tracking Informaion,Demographic Information,Disease Information,Cancer Therapy

Study ID: 103369 Clinical Study ID: 103369 Study Title: A Randomized Phase III Study of Cisplatin Versus Cisplatin plus Topotecan Versus MVAC in Stage IVB, Recurrent or Persistent Squamous Cell Carcinoma of the Cervix Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Topotecan Trade Name: Topotecan Study Indication: Cancer

Pre-Study - BASELINE SYMP - 2393103v1.0 - BASELINE SYMP

- 2/6/19 - 1 form, 2 itemgroups, 9 items, 1 language

Itemgroups: BASELINE SYMPTOMS,COMMENTS

Baseline Symptoms form for C3D 3.12 Adopters Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FF084994-8361-14D0-E034-0003BA3F9857

Baseline Symptoms

- 2/6/19 - 1 form, 2 itemgroups, 9 items, 1 language

Itemgroups: Baseline Symptoms,Comments

Baseline Symptoms form for C3D 3.12 Adopters Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FF084994-8361-14D0-E034-0003BA3F9857

A Cross-Over Study of Alcohol Effect on the Pharmacokinetics of Carvedilol - 106904 - Eligibility Question

- 12/13/18 - 1 form, 2 itemgroups, 5 items, 1 language

Itemgroups: Administrative data,Eligibility Question

Study ID: 106904 Clinical Study ID: CRV106904 Study Title: A Randomized, Open-Label, Single-Dose, Four-Period Cross-Over Study to Determine the Effects of Alcohol on the Pharmacokinetics of Carvedilol CR Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: carvedilol Trade Name: Coreg CR,Coreg Study Indication: Hypertension

Please use this form for feedback, questions and suggestions for improvements.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.